Madam Speaker, I want to thank the member opposite for asking a really important question. I know he has asked similar questions before.
As I said earlier in the House, our focus is to make sure that we approve medications through Health Canada, but do so in a manner that maintains the safety of medications for Canadians. We cannot afford to ever take shortcuts that could jeopardize the lives of Canadians.
Of course, through the pandemic, we learned a lot of lessons. We are looking at ways to improve the approval process, and we will continue to work on that.